Geographic accessibility to clinical trials for advanced cancer in the United States

JAMA Internal Medicine

Volumn 175, Issue 2, 2015, Pages 293-295

  Galsky, Matthew D ^a   Stensland, Kristian D ^a   McBride, Russell B ^b   Latif, Asma ^a   Moshier, Erin ^a   Oh, William K ^b   Wisnivesky, Juan ^b  

^a Tisch Cancer Institute   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; BREAST METASTASIS; CANCER MORTALITY; CANCER PATIENT; CLINICAL TRIAL (TOPIC); COLORECTAL CANCER; GEOGRAPHIC DISTRIBUTION; GEOGRAPHY; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HUMAN; LETTER; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; PROSTATE CANCER; TIME; TRAVEL; UNITED STATES; NEOPLASMS;

CLINICAL TRIALS AS TOPIC; HEALTH SERVICES ACCESSIBILITY; HUMANS; NEOPLASMS; UNITED STATES;

EID: 84922269119     PISSN: 21686106     EISSN: 21686114     Source Type: Journal    
DOI: 10.1001/jamainternmed.2014.6300     Document Type: Letter

References (6)

1. National Comprehensive Cancer Centerwebsite.www.nccn.org. Accessed May 13, 2014.
2. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA. 2004;291(22):2720-2726.
3. Lara PN Jr, Higdon R, Lim N, et al. Prospective evaluation of cancer clinical trial accrual patterns. J Clin Oncol. 2001;19(6):1728-1733.
4. Meropol NJ, Buzaglo JS, Millard J, et al. Barriers to clinical trial participation as perceived by oncologists and patients. J Natl Compr Canc Netw. 2007;5(8): 655-664.
5. Zarin DA, Tse T, Williams RJ, Califf RM, Ide NC. The ClinicalTrials.gov results database: update and key issues. N Engl J Med. 2011;364(9):852-860.
6. English R, Lebovitz Y, Griffin R. Transforming Clinical Research in the United States: Challenges and Opportunities:Workshop Summary.Washington, DC: National Academies Press; 2010.